期刊文献+

β-肌球蛋白重链基因Ala26Val突变——中国人肥厚型心肌病热点突变 被引量:19

Ala26Val mutation in beta myosin heavy chain gene: a hot spot mutation in Chinese hypertrophic cardiomyopathy
原文传递
导出
摘要 目的 研究中国人肥厚型心肌病致病基因 ,分析基因型与临床表型的关系。方法 在86例肥厚型心肌病患者及 12 0例正常对照中进行 β 肌球蛋白重链 (β MHC)基因扫描 ,聚合酶链反应(PCR)扩增其功能区的外显子片段 ,双脱氧末段终止法测序。对阳性结果者进行家系调查 ,收集临床资料 ,分析其临床表型。结果 在 3个家系及 1例散发患者中发现 β MHC基因第 3号外显子的Ala2 6Val错义突变 ,正常对照组同一位置未见异常。 3个家系临床表型不同。结论 β MHC基因Ala2 6Val突变是中国人肥厚型心肌病的热点突变 ,其临床表型的异质性 ,提示多因素参与了肥厚型心肌病的发生和发展。 Objective To study the disease causing gene mutation in Chinese suffering from hypertrophic cardiomyopathy(HCM) and to analyze the correlation between genotype and phenotype Methods Eighty six unrelated patients with HCM and 120 controls were chosen for the study The exons in the functional regions of the β myosin heavy chain (β MHC) gene were amplified with PCR and the products were sequenced The relation between genotype and phenotype was analyzed Results We identified an Ala26Val missense mutation in the exon 3 of β MHC gene in three families and one sporadic patient The phenotypes of the three families were different The 120 controls were normal in the genetic test Conclusions The Ala26Val mutation may be the hot spot mutation in Chinese HCM. The heterogeneity of phenotype suggests that multiple factors are involved in the pathogenesis of HCM
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2002年第8期473-476,共4页 Chinese Journal of Cardiology
关键词 Β-肌球蛋白重链 基因Ala26Val 肥厚型心肌病 临床表型 基因突变 发病机制 Cardiomyopathy, hypertrophic Myosin heavy chain Mutation, missense Phenotype
  • 相关文献

参考文献13

  • 1Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2001, 33:655-670.
  • 2Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 2001, 104:557-567.
  • 3Bonne G, Carrier L, Richard P, et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res, 1998, 83:580-593.
  • 4Rayment I, Rypniewski RW, Schmidt-Base K, et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science, 1993, 261:50-58.
  • 5Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest, 1994, 93:280-285.
  • 6Niimura H, Bachinski LL, Sangwatanaro JS, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med, 1998, 338:1248-1257.
  • 7Ortlepp JR, Vosberg HP, Reith S, et al. Genetic polymorphisms in the renin- angiotensin -aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart, 2002, 87:270-275.
  • 8陆林,于金德,况少青,何汝敏,龚兰生.血管紧张素转化酶基因缺失多态性与肥厚型心肌病的关系[J].临床心血管病杂志,1996,12(3):137-139. 被引量:7
  • 9Futterman LG, Myerburg R. Sudden death in athletes: an update. Sports Med, 1998, 26:335-350.
  • 10Marian AJ. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers. Clin Cardiol, 1995, 18:189-198.

二级参考文献1

共引文献17

同被引文献281

引证文献19

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部